Skip to main content

Deck.blue brings a TweetDeck experience to Bluesky users

With over 3 million users and plans to open up more broadly in the months ahead, Bluesky is still establishing itself as an alternative to Twitter/X. However, that hasn’t stopped the developer community from embracing the project and building tools to meet the needs of those fleeing the now Elon Musk-owned social network, formerly known […] © 2024 TechCrunch. All rights reserved. For personal use only. from TechCrunch https://ift.tt/TBbEAPF
Post a Comment

Nigeria’s Remedial Health gets QED backing in $12M round

Remedial Health, a Nigerian startup digitizing pharmacies and bringing efficiency to the pharmaceutical value chain, has raised $12 million Series A equity-debt funding, to scale operations in the West African country.

Fintech VC firm QED Investors co-led the round, banking on embedded financial opportunities like payments, and lending in the pharmaceutical sector. This is QED’s third investment in Africa after its involvement in the Moniepoint (formerly TeamApt), and Flapkap deals last year. Ventures Platform, also co-led the round, which saw the participation of existing investors like Y Combinator, Tencent and Gaingels.

Pharmacies and hospitals use Remedial Health’s platform to order pharmaceutical products sourced from reliable and trusted manufacturers and verified distributors. This helps to stem erratic prices, and the supply of fake and substandard products that are behind thousands of preventable deaths in Nigeria, and Africa at large. It also ensures a proper handling of the products, which can’t be said of the open drugs market in Nigeria.

QED closes on $925M to back fintech startups globally

A recent report by Nigeria’s National Agency for Food and Drug Administration and Control estimates that about 15% of the medicine sold in the country is fake or sub-standard. Besides, it is estimated by the United Nations Office on Drugs and Crime, that half a million people die in sub-Saharan Africa owing to substandard or counterfeit medicine.

Remedial Health gets $4 million debt funding to scale inventory financing

Founded by Samuel Okwuada (CEO), and Victor Benjamin (COO) in 2021, Remedial Health plans to use the new funding to deepen its operations in Nigeria. The funding includes $4 million debt to help it scale inventory financing.

Okwuada told TechCrunch that priority at the moment remains on increasing penetration in 34 states by getting more pharmacies and hospitals signed up, especially in rural areas, where demand is growing.

“We are seeing more growth in rural areas, because they are difficult to reach, and are far from major open drug markets in Nigeria,” said Okwuada, adding that the startup currently has a “considerable market share” in at least half of the 34 of 36 states it operates in within Nigeria.

The YC-alumni currently serves over 5,000 pharmacies and hospitals, having grown its client count by 3X since November last year. It sources the over 8,000 products it sells from 300 manufacturers, among them GSK, Pfizer and AstraZeneca.

Its inventory financing, which enables its clients to restock without upfront payment, has helped grow its client count, and revenues by 7X over the last 10 months too.

“We are a B2B business and we are able to provide inventory to these pharmacies without requesting cash up-front, or at the point of delivery… We’ve seen them grow their businesses, open additional branches because they are able to get credit,” said Okwuada.

Remedial’s platform enables its customers to manage their operations including inventory management (through an app too), accounting, and financial reporting. It also provides real-time market intelligence that informs manufacturers on production and distribution.

Okwuada said its customers receive orders within 24 hours. The startup has a network of distribution hubs, spread across the regions it serves, and does last-mile delivery in-house or through partners. Other startups bringing efficiency in the pharmaceutical value chain include MyDawa, and DrugStoc.

Commenting on the investment, QED Investors partner, and head of Africa, Gbenga Ajayi said in a statement: “The success that Remedial Health has enjoyed to date is an indication of the market gap that exists, and their value in providing effective holistic services to thousands of pharmacies across Nigeria.”

“QED is particularly excited about the embedded financial services opportunities within the vertical — the ability to provide payments, embedded lending and other fintech solutions to this underserved but very crucial sector.”

Nigeria’s YC-backed Remedial Health raises $4.4M seed funding

Kenya’s MyDawa aims to be an all-in-one health platform backed by $20 million funding



from TechCrunch https://ift.tt/oqlKt5g
Labels:

Comments

Post a Comment

Popular posts from this blog

Sam Altman launches eyeball-scanning Worldcoin to ‘drastically increase economic opportunity’

Worldcoin Foundation, Sam Altman’s crypto startup with the vision to “drastically increase economic opportunity,” has started the rollout of its services in 20 nations. The startup said it’s rolling out its identity technology as well as the token internationally. Individuals can download World App, the startup’s protocol-compatible wallet software and visit an Orb, the startup’s helmet-shaped eyeball-scanning verification device, to receive their World ID. As TechCrunch has previously noted , Worldcoin is perhaps one of the most audacious efforts to bribe the world to embrace their currency. The startup, founded by OpenAI CEO Altman and Alex Blania, wants to put a crypto wallet (and some of their currency) onto every human’s smartphone, but in order to do so they have to build a way to determine whether someone is a unique human. “If successful, we believe Worldcoin could drastically increase economic opportunity, scale a reliable solution for distinguishing humans for AI online wh...
Post a Comment
Read more

A judge dismissed Phhhoto’s antitrust suit against Meta

A U.S. District Court Judge for the Eastern District of New York threw out a lawsuit against Meta this week that had been simmering for a year and a half. The suit, filed in late 2021 by now-shuttered social app Phhhoto, alleged that Meta violated federal antitrust law by copying its core features with the Instagram-adjacent video looping app Boomerang . Like Boomerang, which Meta launched in October of 2015 and later integrated into Instagram itself, Phhhoto invited users to share very short GIF-like loops. U.S. District Judge Kiyo Matsumoto ultimately granted Meta’s motion to dismiss the complaint due to time-limits imposed by the relevant statutes of limitations. “Phhhoto has failed in its 69-page Amended Complaint of 222 paragraphs to allege sufficient facts that cure the untimeliness of all of its federal claims,” Matsumoto wrote in the opinion, calling the possibility of any amendment to resolve the issue of the lawsuit’s timing “futile.” New antitrust suit from Phhhoto a...
Post a Comment
Read more

Ivella is the latest fintech focused on couples banking, with a twist

Money can make people moody. There are layers of privilege, or lack thereof, that can make even the simplest conversation about bills feel like baggage to deal with. Translate that discomfort to relationships and it can feel like an awkward — and fragmented — dance on who pays which bill when (and how). Ivella , a Santa Monica-based startup, wants to build banking products for couples to take away some of these tensions. Led by CEO and co-founder Kahlil Lalji , the startup is launching with a split account product that just raised $3.5 million in funding from Anthemis, Financial Venture Studio and Soma Capital. Other investors include Y Combinator, DoNotPay CEO Joshua Browder and Gumroad CEO Sahil Lavingia. Lalji, who helped creators with digital content before jumping into the world of fintech, says that the startup was born out of his own frustration at the expectation that couples would just use Venmo unless they were married. The best solution, so far, has been joint accounts...
Post a Comment
Read more